In8Bio (INAB) Share-based Compensation (2020 - 2026)
In8Bio (INAB) reported Share-based Compensation of $352,000 for Q2 2026, down 63.1% from $955,000 a year earlier and down 12.2% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, In8Bio's Share-based Compensation came in at $2.16 million, down 50.7% year-over-year; for FY2025, it was $3.19 million, down 36.2% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 55.0% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $5 million in FY2024 (+14.4%), $4.37 million in FY2023 (+26.0%), $3.47 million in FY2022 (+57.9%) and $2.2 million in FY2021 (+514.8%).
- The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation since Q4 2020.
- Year over year, Share-based Compensation has now declined in each of the last seven quarters, with an average decline of 29.1% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 633.8%); the low point was Q2 2026 (a decline of 63.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $401,000 (Q1 2026), $711,000 (Q4 2025) and $692,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - | 352,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 352,000.00 |
| Mar 31, 2026 | 401,000.00 |
| Dec 31, 2025 | 711,000.00 |
| Sep 30, 2025 | 692,000.00 |
| Jun 30, 2025 | 955,000.00 |
| Mar 31, 2025 | 831,000.00 |
| Dec 31, 2024 | 825,000.00 |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | 859,000.00 |
| Dec 31, 2022 | 922,000.00 |
| Sep 30, 2022 | 897,000.00 |
| Jun 30, 2022 | 884,000.00 |
| Mar 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 965,000.00 |
| Sep 30, 2021 | 477,000.00 |
API Access
In8Bio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();